ROCKVILLE, Md.--(BUSINESS WIRE)--Genesys BioLabs, a division of 20/20 GeneSystems, Inc. announces today the launch of PAULA’s test, a blood test for the early detection of lung cancer, addressing the need for a widely useable early detection protocol for asymptomatic patients. The test was introduced to several dozen D.C. area physicians over the past several weeks including a group of lung cancer specialists who attended this past weekend’s Lung Cancer 2012 conference at the Hotel Monoco in Washington, D.C.
